The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study von Bamias, Aristotelis, Karavasilis, Vasilios, Gavalas, Nikolaos, Tzannis, Kimon, Samantas, Epaminontas, Aravantinos, Gerasimos, Koutras, Angelos, Gkerzelis, Ioannis, Kostouros, Euthymios, Koutsoukos, Konstantinos, Zagouri, Flora, Fountzilas, George, Dimopoulos, Meletios-Athanasios

Volltext

OLAPARIB: A promising PARP Inhibitor for the treatment of ovarian cancer von Soupos, Nikolaos, Laschos, Konstantinos, Bournakis, Evangelos, Kostouros, Euthymios, Aravantinos, Gerasimos

Volltext

Guillain-Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Review of the Literature von Kyriazoglou, Anastasios, Liontos, Michael, Papadopoulos, Costantinos, Bilali, Afroditi, Kostouros, Euthymios, Pagoni, Stamatina, Doumas, Konstantinos, Dimopoulos, Meletios Athanasios, Bamias, Aristotelis

Volltext

Risk for vascular thromboembolic events (VaTEs) in patients (pts) with advanced urinary tract cancer (aUTC) treated with chemotherapy von Bamias, Aristotelis, Tsironis, George, Dimitriadis, Ioannis, Tzanis, Kimon, Tsiara, Anna, Xirokosta, Aikaterini, Kaparelou, Maria, Kyriazoglou, Anastasios, Cohen, Abis, Barbarousi, Despoina, Koutsoukos, Konstantinos, Liontos, Michael, Zakopoulou, Roubini, Kostouros, Euthymios, Pagoni, Stamatina, Matsouka, Charis, Dimopoulos, Meletios A.

Volltext